1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CAPLIN POINT LABORATORIES LTD.
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT | BSE: 524742
Iran War Impact
Ask MarketMind AI
2407.80 76.80 (3.29%)
238.2K
NSE+BSE Volume

NSE 12 Jun, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

Caplin Point Labs - CAPLIPOINT - stock price prediction, stock forecast, target price, analyst ratings from 2 analysts

Caplin Point Labs has a share price target of Rs 2505, revenue growth forecast of 13.8%, and profit growth estimate of 11.2% for FY27, based on top 2 analyst calls.